Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Pharmacon: Jurnal Farmasi Indonesia
Suwirtawati, Ni Putu Dewanty
Unknown Affiliation
Health Professions Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Evaluation of Antiretroviral and Tuberculosis Therapy Based on Clinical Outcomes in Patients With HIV/AIDS and Tuberculosis Co-Infection at Regional General Hospital in Denpasar Kurnianta, Putu Dian Marani; Suwirtawati, Ni Putu Dewanty; Dhrik, Mahadri
Pharmacon: Jurnal Farmasi Indonesia Volume 22, No 2 (2025)
Publisher : Universitas Muhammadiyah Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23917/pharmacon.v22i2.12652

Abstract

Human immunodeficiency virus and tuberculosis (HIV-TB) co-infection presents a significant challenge in Denpasar due to high incidence and complex treatment. This retrospective single-cohort study aimed to analyze the relationship between the results of therapy evaluation and the clinical outcomes in patients with HIV-TB. Secondary data from 20 HIV-TB treatment at a Regional General Hospital in Denpasar during 2022-2024 were evaluated. Fisher’s Exact test was performed to analyze the association between adherence to antiretroviral therapy (ART) and antituberculosis therapy (ATT), as per the guidelines, and their treatment success. Results showed predominance in males of productive age (60%), with cough as the most common symptom (75%), and 80% patients at HIV stage 4. All patients (N=20) received first-line ART and ATT. However, only 20% completed the treatment algorithm and 40% achieved treatment success. Although no significant association was found between treatment evaluation and success (p = 0.101), the relevant findings in this study emphasized the important role of rational drug use based on guidelines.  Further studies with larger samples and a prospective approach are needed to explore additional factors affecting clinical outcomes of patients with HIV-TB undergoing therapy according to the established guidelines.
Co-Authors Dhrik, Mahadri Putu Dian Marani Kurnianta